Use of the Nerivio Remote Electrical Neuromodulation Device to Treat Migraines While Pregnant is safe.

Published Date: 14 Sep 2023

In terms of outcomes such as newborn weight, miscarriage rate, preterm birth rate, birth defect rate, stillbirth rate, and rate of newborns meeting developmental milestones three months after birth, Nerivio treatment was comparable to controls.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

2.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

3.

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

4.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

5.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot